Elimination of CD8 T-cells completely abolished the therapeutic benefit of PLK1122DC_TriVax vaccination, indicating that CD8 T-cells are crucial for the controlling of established C1498 myeloid leukaemia (Fig. 2c, d). The gene discussed is CD8A; the disease is myeloid leukemia.